MCRB - Seres Therapeutics Inc
9.32
0.190 2.039%
Share volume: 60,322
Last Updated: 03-09-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$9.13
0.19
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-08-2024 | 08-13-2024 | 11-13-2024 | 03-13-2025 | 05-07-2025 | 08-06-2025 | 11-05-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 351.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 351.000 K | |
| nan% | nan% | nan% | nan% | inf% | ||||
| Operating expenses | 37.168 M | 33.934 M | 29.170 M | 17.511 M | 23.709 M | 23.192 M | 22.092 M | |
| Selling general and admin | 15.466 M | 16.059 M | 12.710 M | 8.948 M | 11.888 M | 10.253 M | 9.476 M | |
| Research and development | 21.702 M | 17.875 M | 16.460 M | 8.563 M | 11.821 M | 12.939 M | 12.616 M | |
| Total expenses | 39.586 M | 31.345 M | 29.170 M | 21.214 M | 27.236 M | 24.881 M | 22.828 M | |
| -20.82% | -6.94% | -27.27% | 28.39% | -8.65% | -8.25% | |||
| Operating income | -39.586 M | -31.345 M | -29.170 M | -21.214 M | -27.236 M | -24.881 M | -22.477 M | |
| Ebit | -37.118 M | -30.653 M | -51.687 M | -10.280 M | 32.064 M | -20.401 M | 7.586 M | |
| Pretax income | -40.133 M | -32.870 M | -51.035 M | -1.733 M | 32.682 M | -19.855 M | 8.204 M | |
| -18.10% | 55.26% | -96.60% | -1,985.86% | -160.75% | -141.32% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -40.133 M | -32.870 M | 88.776 M | -15.637 M | 32.682 M | -19.855 M | 8.204 M | |
| 18.10% | 370.08% | -117.61% | 309.00% | -160.75% | 141.32% |